PropertyValue
?:abstract
  • An 84-year-old woman with hypertension, Alzheimer\'s disease, and chronic kidney disease presented with fever and was diagnosed with corona virus disease 2019 (COVID-19). During the hospitalization, she experienced unexpected sinus bradycardia with prolonged QTc, which was thought to be closely related to the short-term use of hydroxychloroquine (HCQ), an old drug used to treat malaria and autoimmune diseases, but now used against COVID-19. The cardiac side effects of HCQ were rare, seen with short-term and low-dose use. With the COVID-19 pandemic, this case alerts clinicians to be aware of the arrhythmogenic effects of HCQ when it is used as an antiviral drug, especially in patients with preexisting cardiovascular diseases.
?:creator
?:doi
  • 10.1536/ihj.20-271
?:doi
?:journal
  • International_heart_journal
?:license
  • unk
?:pmid
?:pmid
  • 32921678
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Suspected Hydroxychloroquine-Induced Sinus Bradycardia and QTc Prolongation in a Patient with COVID-19.
?:type
?:year
  • 2020-09-12

Metadata

Anon_0  
expand all